2025-2026 Regular Session

SB 5240

Anaphylaxis med. in schools

Floor Vote

Jurisdiction

Washington

Session

2025-2026 Regular Session

Official source

Chamber

Senate

Session

2025-2026 Regular Session

Jurisdiction

Washington

Bill overview

Concerning anaphylaxis medications in schools.

Positions across the state

No public positions recorded for this legislation.

Arguments in favor

Reasons to support this legislation.

No arguments in favor have been submitted.

Submit yours

Arguments opposed

Reasons to oppose this legislation.

No arguments opposed have been submitted.

Submit yours

Legislative history

2025-01-14Senate

First reading, referred to Early Learning & K-12 Education.

2025-02-11Senate

EDU - Majority; 1st substitute bill be substituted, do pass.

2025-02-11Senate

EDU - Majority; 1st substitute bill be substituted, do pass.

2025-02-12Senate

Passed to Rules Committee for second reading.

Vote map

Senate districts

Loading map data

0 districts with vote data

Nay

Yea

Floor votes and chamber actions

Recorded roll calls list how each member voted. Unanimous consent or voice vote appears in the official action history without a roll call; no member-level tally is available for those steps.

Recorded roll calls

Read the latest version inline or switch to a previous version.

SB 5240

Bill overview

Sponsors

Primary sponsor

Cosponsors

Positions across the state

Arguments in favor

Arguments opposed

Vote map

Floor votes and chamber actions

Recorded roll calls

Bill text

Positions across the state

Vote map

Floor votes and chamber actions

Recorded roll calls